CytoRecovery Joins BioTools Innovator 2024 Cohort

CytoRecovery has been selected as one of the top 20 life sciences companies to join the prestigious BioTools Innovator 2024 Cohort. This accelerator program, which provides customized mentorship and funding opportunities, aims to support startups in the life sciences tools and diagnostics sector. CytoRecovery will benefit from the guidance of senior industry leaders and engage with peers and advisors throughout the four-month program. This recognition highlights CytoRecovery's innovative contributions to advancing human health through cutting-edge biotechnology solutions.

For more information, visit BioTools Innovator.